Navigation Links
InVitria Presents Zap-CHO Performance Results at PEACe Conference
Date:9/23/2009

Zap-CHO: a new and innovative CHO cell culture supplement from InVitria designed to deliver superior growth, maximum antibody productivity and faster cell line development. Performance results were presented to attendees of the PEACe Conference in Jackson Hole, WY this week.

Fort Collins, CO September 23, 2009 / b3c newswire / C A new powerful and robust cell culture supplement for CHO (Chinese hamster ovaries) cell line enhancement called Zap-CHO was featured this week at the 9th Protein Expression in Animal Cells (PEACe) Conference in Jackson Hole, Wyoming.
Zap-CHO is a significant breakthrough in mammalian cell culture systems, said Dr. Steve Pettit, InVitrias Director of Cell Culture Development. With the development of Zap-CHO, InVitria has created a performance enhancing CHO media supplement that is the first animal free supplement capable of replacing fetal bovine serum (FBS) without sacrificing performance and maintaining a well defined media. Since Zap-CHO is a defined and animal component-free product, it is well suited for commercial, chemically-defined and serum- and animal-free cell culture media formulations, said Dr. Pettit.
Dr. Pettit presented the Zap-CHO performance results during the technical workshop and he also presented during the poster session at PEACe on Tuesday. Copies of the poster and presentation are available by contacting InVitria at the email address or phone number listed below.
Zap-CHO is a next generation media supplement that delivers consistent cell culture performance. Previously, only FBS could deliver equivalent performance, but safety concerns of a fetal bovine component in cell culture media forced many customers away from this component. In the last decade, customers have eliminated FBS in cell culture media only to lose cell culture performance. To regain the lost performance, many began adding hydrolysates to the media. However, hydrolysates introduced significant variability, leading to failed experiments and production failures. Zap-CHO addresses these concerns and provides significant benefits in CHO cell culture, including:
*Faster cell line development and seed train expansion
*Animal component-free media
*Consistency of a defined media component
*Biomanufacturing optimization and improved production economics
*Better and more predictable performance in cell culture research and development
Now, with Zap-CHO, customers can get the animal free benefit of hydrolysates, the performance of FBS and the consistency of a defined media, said Randy Semadeni, InVitrias Vice President of Business Development. It is a new era for the cell culture industry.


About InVitria - www.InVitria.com
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.


For more information about InVitrias products or to obtain a copy of Dr. Pettits Zap-CHO poster or presentation, please contact InVitria at info@invitria.com or call 1-800-916-8311.


'/>"/>
b3c newswire

Related biology news :

1. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
2. InVitria Sponsors ESACT 2009 in Dublin, Ireland
3. InVitria to Unveil Powerful Cell Culture Media Component ZAP-CHO
4. InVitria Announces Launch of Recombinant Albumin for Diagnostics
5. The BBVA Foundation presents its Frontiers of Knowledge Awards
6. Versartis presents positive preclinical data on 2 product candidates at ENDO 09
7. REGiMMUNE presents enhanced efficacy data in preclinical transplantation models
8. Biolex presents Locteron US Phase 2a hepatitis C data at EASL
9. GSA special paper presents new studies of Western US earth motion
10. AIUM Presents 2009 Joseph H. Holmes Pioneer Awards
11. AIUM presents 2009 Memorial Hall of Fame awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... G. Fujimoto, Ph.D ., the Elihu Thomson Professor of Electrical Engineering and Computer ... Research Award winner. Presented annually, the award recognizes an individual who has ...
(Date:7/20/2017)... ... , ... VIC Technology Venture Development™ (VIC™), is pleased to announce ... addition continues to strengthen and diversify VIC’s board. , "We are excited to have ... highly accomplished business executive with a broad range of experience directly relevant to VIC ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... solution to make clinical trial sites and study participants truly unified. TrialKit, a ... compliant (FDA 21 CFR Part 11) research studies entirely on mobile devices. With ...
(Date:7/18/2017)... , ... July 18, 2017 , ... ... the United States Patent and Trademark Office for its Patent Applications 14/858,857 and ... Office’s allowances of these patent applications further expand the protection of G-CON’s R&D ...
Breaking Biology Technology: